DrxNoze Nosebleed Relief (ByzMed, LLC)


Welcome to the PulseAid listing for the DrxNoze Nosebleed Relief drug offered from ByzMed, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: ByzMed, LLC
NON-PROPRIETARY NAME: Achillea Millefolium, Marrubium Vulgare, Stachys Betonica, Urtica Dioica
SUBSTANCE NAME: ACHILLEA MILLEFOLIUM; MARRUBIUM VULGARE; STACHYS OFFICINALIS; URTICA DIOICA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SWAB
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-02-01
END MARKETING DATE: 0000-00-00


DrxNoze Nosebleed Relief HUMAN OTC DRUG Details:

Item DescriptionDrxNoze Nosebleed Relief from ByzMed, LLC
LABELER NAME: ByzMed, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1; 1; 1; 1([hp_X]/1.5mL; [hp_X]/1.5mL; [hp_X]/1.5mL; [hp_X]/1.5mL)
START MARKETING DATE: 2014-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58092-001_a47683ea-aa14-433c-bb8f-3aa808595645
PRODUCT NDC: 58092-001
APPLICATION NUMBER:

Other ACHILLEA MILLEFOLIUM; MARRUBIUM VULGARE; STACHYS OFFICINALIS; URTICA DIOICA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ByzMed, LLCDrxNoze Nosebleed Relief